<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03495297</url>
  </required_header>
  <id_info>
    <org_study_id>NL64634_018_18</org_study_id>
    <nct_id>NCT03495297</nct_id>
  </id_info>
  <brief_title>A Randomised Trial of S-ICD Implantation With and Without Defibrillation Testing</brief_title>
  <acronym>PRAETORIAN-DFT</acronym>
  <official_title>A Prospective Randomised CompArative Trial of SubcutanEous ImplanTable CardiOverter-DefibrillatoR ImplANtation With and Without DeFibrillation Testing</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Boston Scientific Corporation</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will test the hypothesis that implantation of a subcutaneous implantable
      cardioverter defibrillator (S-ICD) without performing a defibrillation test is non-inferior
      to S-ICD implant with a defibrillation test with regards to the primary endpoint failed first
      shock in a spontaneous arrhythmia episode when implant position is confirmed with PRAETORIAN
      score.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Implantable Cardioverter Defibrillator (ICD) implant improves survival in patients with a
      higher risk for sudden cardiac death. There are 2 types of ICD available; transvenous ICD
      (TV-ICD) and subcutaneous ICD (S-ICD). During ICD implant, defibrillation testing (DFT) is
      performed to test functionality of the device. However, DFT can be associated with
      complications such as inability to convert, complications arising from general anaesthesia,
      prolonged resuscitation, stroke and death. Whereas DFT may be associated with complications,
      the benefit of DFT is debated as literature shows there is only a modest average effect of
      DFT, if any, on mortality, shock efficacy or safety. Recently it was shown in a randomized
      controlled trial called 'SIMPLE' that routine defibrillation testing of TV-ICDs at the time
      of implant does not improve shock efficacy or reduce arrhythmic death. For S-ICD there is
      only limited data available of the effect of DFT on S-ICD efficacy. Data have however shown
      that the conversion efficacy of the S-ICD is comparable to TV-ICD.

      DFT is currently performed in standard S-ICD implants, but is omitted in specific cases.
      However, an alternative method to evaluate the correct position may be desired when omitting
      DFT. The PRAETORIAN Score is developed using computer modelling data on factors influencing
      defibrillation thresholds. The PRAETORIAN score represents the chance of a patient having an
      elevated defibrillation threshold and consequently failing a DFT or conversion of a
      spontaneous arrhythmia episode. The score was retrospectively validated in two studies with
      180 and 321 patients.

      It was reported that most S-ICD implants are performed under general anesthesia, however
      other anesthesia protocols are used as well. One of the most predominant factors to use
      general anesthesia is the performance of the DFT. If this is omitted, other anesthesia
      protocols may be a good option for many patients as well.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 7, 2018</start_date>
  <completion_date type="Anticipated">September 2023</completion_date>
  <primary_completion_date type="Anticipated">September 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Failed first appropriate shock in a spontaneous episode</measure>
    <time_frame>40 months</time_frame>
    <description>Number of patients having experiences a failed first appropriate shock in a spontaneous arrhythmia episode</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>DFT related complications</measure>
    <time_frame>24 hours or 30 days</time_frame>
    <description>Number of patients experiencing DFT related complications occurring within 24h or 30 days after DFT</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PRAETORIAN Score</measure>
    <time_frame>up to 24 hours</time_frame>
    <description>Implant position will be scored using the PRAETORIAN score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain post implant</measure>
    <time_frame>1-4 hours post implant</time_frame>
    <description>Pain score measured with McGill questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Appropriate ICD therapy</measure>
    <time_frame>40 months</time_frame>
    <description>Shocks given for VT or VF</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inappropriate ICD therapy</measure>
    <time_frame>40 months</time_frame>
    <description>Shocks given for anything else than VT or VF</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall DFT conversion success</measure>
    <time_frame>40 months</time_frame>
    <description>The percentage of patients with at least one induced episode teminated by an S-ICD shock within five seconds post shock delivery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Successful DFT</measure>
    <time_frame>40 months</time_frame>
    <description>A successful DFT is defined as conversion to SR or AF in less than 5 seconds from appropriate shock delivery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to therapy</measure>
    <time_frame>40 months</time_frame>
    <description>Time to therapy is the time between the start of VT or VF in a treated episode until the first shock in seconds.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to succesful therapy</measure>
    <time_frame>40 months</time_frame>
    <description>Time to successful therapy is the time between the start of VT or VF until the first successful shock.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Shock efficacy</measure>
    <time_frame>40 months</time_frame>
    <description>Percentage of appropriate shocks that was successfull</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Conversion efficacy within 5 shocks in spontaneous episodes</measure>
    <time_frame>40 months</time_frame>
    <description>Conversion efficacy within 5 shocks in spontaneous episodes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>S-ICD related complications</measure>
    <time_frame>40 months</time_frame>
    <description>S-ICD related complications requiring invasive intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MACE post DFT</measure>
    <time_frame>30 days</time_frame>
    <description>Number of Major Adverse Cardiac Events after DFT procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac (pre-)syncope</measure>
    <time_frame>40 months</time_frame>
    <description>Number of episodes of cardiac (pre-)syncope</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac decompensation</measure>
    <time_frame>40 months</time_frame>
    <description>Number of episodes of cardiac decompensation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>40 months</time_frame>
    <description>All cause mortality; arrhythmic death; cardiovascular death; unexplained death</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of hospitalization</measure>
    <time_frame>40 months</time_frame>
    <description>Length of hospitalization post implant (nights)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Device or lead repositioning</measure>
    <time_frame>40 months</time_frame>
    <description>Number of procedures for device or lead repositioning</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICD related infection</measure>
    <time_frame>40 months</time_frame>
    <description>Number of infections related to implanted ICD</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Composite complications 30 days after implant</measure>
    <time_frame>30 days</time_frame>
    <description>Number of patients experiencing complications occurring within 30 days after implant</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">965</enrollment>
  <condition>Ventricular Arrythmia</condition>
  <arm_group>
    <arm_group_label>S-ICD Implant with defibrillation test</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients undergoing de novo S-ICD implantation including induction of VF and defibrillation testing post-implant</description>
  </arm_group>
  <arm_group>
    <arm_group_label>S-ICD Implant without defibrillation test</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients undergoing de novo S-ICD implantation without induction of VF and defibrillation testing post-implant</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ommitence of defibrillation testing</intervention_name>
    <description>Induction of a ventricular arrhythmia to test proper arrhythmia detection and termination by the implanted device is omitted</description>
    <arm_group_label>S-ICD Implant without defibrillation test</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who meet current guidelines for ICD therapy and intent to undergo a de novo
             implant procedure for an S-ICD

          -  Patients must pass S-ICD screening per local routine

          -  Patients over 18 years of age, willing and capable to give informed consent

          -  Patients must be willing and capable of complying to follow up visits

          -  Patient must be eligible for either DFT strategy per physician discretion

        Exclusion Criteria:

          -  Patient with a life expectancy shorter than 12 months due to any medical condition

          -  Patients known to be pregnant

          -  Patients with intracardiac thrombus

          -  Patients with atrial fibrillation without appropriate anticoagulation

          -  Patients likely to undergo heart transplant within 12 months

          -  Patients with LVAD

          -  Patients with other contra-indications for DFT per physician's discretion
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Reinoud E Knops, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Reinoud E Knops, MD, PhD</last_name>
    <phone>+31205666555</phone>
    <email>r.e.knops@amc.nl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lonneke Schats - Smeding, PhD</last_name>
    <phone>+31205665424</phone>
    <email>l.smeding@amc.nl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Adventh Health System</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32803</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Leann Goodwin</last_name>
      <email>Leann.Goodwin@AdventHealth.com</email>
    </contact>
    <investigator>
      <last_name>Naushad Shaik, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Emory University Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jessica Nelson</last_name>
      <email>jessica.nelson@emory.edu</email>
    </contact>
    <investigator>
      <last_name>Mikhael F El-Chami, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CorVita Science Foundation</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60605</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin C Burke, DO</last_name>
      <email>mburke@corvitahealth.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mount Sinai Beth Israel</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10003</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Samuel Hanon, MD</last_name>
      <email>samuel.hanon@mountsinai.org</email>
    </contact>
    <investigator>
      <last_name>Samuel Hanon, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Icahn School of Medicine at Mount Sinaï</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marc A Miller, MD</last_name>
      <email>marc.miller@mountsinai.org</email>
    </contact>
    <investigator>
      <last_name>Marc A Miller, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Erlanger Health System</name>
      <address>
        <city>Chattanooga</city>
        <state>Tennessee</state>
        <zip>37403</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gina Harris</last_name>
      <email>Geneva.Harris@erlanger.org</email>
    </contact>
    <investigator>
      <last_name>Harish Manyam, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Schleswig-Holstein</name>
      <address>
        <city>Kiel</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hendrik Bonnemeier, MD</last_name>
      <email>hendrik.bonnemeier@uksh.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Schleswig-Holstein, Campus Lübeck</name>
      <address>
        <city>Lübeck</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antje Maass</last_name>
      <email>antje.maass@uksh.de</email>
    </contact>
    <investigator>
      <last_name>Roland R Tilz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Mannheim</name>
      <address>
        <city>Mannheim</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jürgen Kuschyk, MD</last_name>
      <email>Juergen.Kuschyk@umm.de</email>
    </contact>
    <contact_backup>
      <last_name>Boris Rudic, MD</last_name>
      <email>boris.rudic@umm.de</email>
    </contact_backup>
    <investigator>
      <last_name>Jürgen Kuschyk, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Würzburg</name>
      <address>
        <city>Würzburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Christina Moser</last_name>
      <email>Moser_C@ukw.de</email>
    </contact>
    <investigator>
      <last_name>Peter Nordbeck, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Flevoziekenhuis</name>
      <address>
        <city>Almere</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nick Bijsterveld, MD, PhD</last_name>
      <email>NBijsterveld@Flevoziekenhuis.nl</email>
    </contact>
    <investigator>
      <last_name>Nick Bijsterveld, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Academic Medical Center Amsterdam</name>
      <address>
        <city>Amsterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>L V Vertelman, MSc</last_name>
      <email>l.v.vertelman@amsterdamumc.nl</email>
    </contact>
    <investigator>
      <last_name>R E Knops, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>OLVG</name>
      <address>
        <city>Amsterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jonas S.S.G. de Jong, MD, PhD</last_name>
      <email>J.S.S.G.deJong@olvg.nl</email>
    </contact>
    <investigator>
      <last_name>Jonas S.S.G. de Jong, Md, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Catharina Ziekenhuis</name>
      <address>
        <city>Eindhoven</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria van Eijck</last_name>
      <email>maria.v.eijck@catharinaziekenhuis.nl</email>
    </contact>
    <investigator>
      <last_name>Frank A.L.E Bracke, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UMCG</name>
      <address>
        <city>Groningen</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Alexander M. Maass, MD, PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medisch Centrum Leeuwarden</name>
      <address>
        <city>Leeuwarden</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fleur A.E. Borger van der Burg, MD, PhD</last_name>
      <email>a.e.borgervanderburg@znb.nl</email>
    </contact>
    <investigator>
      <last_name>Fleur A.E. Borger van der Burg, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St Antonius Ziekenhuis</name>
      <address>
        <city>Nieuwegein</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lucas V.A. Boersma, MD, PhD</last_name>
      <email>l.boersma@antoniusziekenhuis.nl</email>
    </contact>
    <investigator>
      <last_name>Lucas V.A. Boersma, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Canisius Wilhelmina Ziekenhuis</name>
      <address>
        <city>Nijmegen</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jan Elders</last_name>
      <email>j.elders@cwz.nl</email>
    </contact>
    <investigator>
      <last_name>H MM Alhashimi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Isala Klinieken</name>
      <address>
        <city>Zwolle</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter-Paul H.M. Delnoy, MD, PhD</last_name>
      <email>p.p.h.m.delnoy@isala.nl</email>
    </contact>
    <investigator>
      <last_name>Peter-Paul H.M. Delnoy, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Basildon and Thurrock Univerity Hospital NHS Foundation Trust</name>
      <address>
        <city>Basildon</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Duncan C Field, MD</last_name>
      <email>Duncan.Field@colchesterhospital.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Duncan Field, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Blackpool Victoria Hospital NHS Foundation Trust</name>
      <address>
        <city>Blackpool</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christopher Cassidy, MD</last_name>
      <email>christopher.cassidy2@nhs.net</email>
    </contact>
    <investigator>
      <last_name>Christopher Cassidy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal Papworth Hospital NHS Foundation Trust</name>
      <address>
        <city>Cambridge</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claire Martin, MD</last_name>
      <email>claire.martin22@nhs.net</email>
    </contact>
    <investigator>
      <last_name>Claire Martin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Heart and Chest Hospital NHS Foundation Trust</name>
      <address>
        <city>Liverpool</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jay D.J. Wright, MD</last_name>
      <email>David.Wright@lhch.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Jay Wright, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Barts Health NHS Trust of the Royal London Hospital</name>
      <address>
        <city>London</city>
        <zip>ÉC1A 7BE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hakam Abbass</last_name>
      <email>hakam.abbass@nhs.net</email>
    </contact>
    <investigator>
      <last_name>Pier Lambiase, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Manchester Heart Center, Manchester Royal Infirmary</name>
      <address>
        <city>Manchester</city>
        <zip>M13 9WL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Amir Zaidi, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Oxford University Hospitals NHS Foundation Trust</name>
      <address>
        <city>Oxford</city>
        <zip>OX3 7LE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Webster</last_name>
      <email>David.Webster@ouh.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Tim R Betts, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sheffield Teaching Hospitals NHS Foundation Trust, Northern General Hospital</name>
      <address>
        <city>Sheffield</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nigel Lewis, MD</last_name>
      <email>nigel.lewis1@nhs.net</email>
    </contact>
    <investigator>
      <last_name>Nigel Lewis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Royal Wolverhampton NHS Trust, the New Cross Hospital</name>
      <address>
        <city>Wolverhampton</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrew Smallwood</last_name>
      <email>andy.smallwood@nhs.net</email>
    </contact>
    <investigator>
      <last_name>Anita Arya, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>Netherlands</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>March 23, 2018</study_first_submitted>
  <study_first_submitted_qc>April 4, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 12, 2018</study_first_posted>
  <last_update_submitted>November 8, 2019</last_update_submitted>
  <last_update_submitted_qc>November 8, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 12, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</investigator_affiliation>
    <investigator_full_name>R.E. Knops</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>subcutaneous implantable cardioverter defibrillator</keyword>
  <keyword>Defibrillation testing</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arrhythmias, Cardiac</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

